(Reuters) - A panel of outside advisers to the U.S. Food and Drug Administration voted against approving Purdue Pharma's experimental fast-acting oxycodone painkiller.
Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49be6bad/sc/19/l/0L0Sreuters0N0Carticle0C20A150C0A90C10A0Cus0Epurdue0Efda0EidUSKCN0ARA2L620A150A910A0DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
No comments:
Post a Comment